Thrombocytopenia Evaluation and Management

Initial Workup

The American Society of Hematology recommends a complete blood count with differential and peripheral blood smear examination to confirm true thrombocytopenia and exclude pseudothrombocytopenia, followed by targeted testing based on clinical presentation and severity 1, 2, 3
A peripheral blood smear examination should be performed immediately to assess platelet morphology, size, and identify platelet clumping 1, 2, 3
A complete blood count with differential is essential to assess for other cytopenias (anemia, leukopenia) that narrow the differential diagnosis 1, 2, 3

The initial evaluation should include a detailed medication history, including heparin, quinidine, sulfonamides, GPIIb-IIIa inhibitors, chemotherapy agents, and over-the-counter medications that can cause drug-induced thrombocytopenia 4
HIV testing should be performed in patients with risk factors 1, 2, 3
A family history of bleeding disorders or thrombocytopenia should be assessed to evaluate for inherited conditions 4

For patients with isolated thrombocytopenia, HIV testing should be performed in patients with risk factors 1, 2, 3
Antiplatelet antibody testing may be considered if immune thrombocytopenia is suspected, though this is not required for diagnosis 3, 4
Bone marrow aspiration and biopsy should be performed in patients with persistent thrombocytopenia lasting more than 6-12 months or those unresponsive to intravenous immunoglobulin (IVIg) 1, 2, 4

The American Society of Hematology recommends that patients with a platelet count <10,000/μL be considered a hematologic emergency requiring immediate hospitalization and urgent evaluation 7
Patients with a platelet count 10,000-20,000/μL are at increased risk of bleeding with minimal trauma and may require hospitalization if significant mucosal bleeding or comorbidities are present 7